{"created":"2025-08-18T01:29:46.950305+00:00","id":2001779,"links":{},"metadata":{"_buckets":{"deposit":"b842bcd7-1a91-4e5c-af65-44a124f96b79"},"_deposit":{"created_by":10,"id":"2001779","owners":[10],"pid":{"revision_id":0,"type":"depid","value":"2001779"},"status":"published"},"_oai":{"id":"oai:ir.jikei.ac.jp:02001779","sets":["25:30:1748221084887:1755477912960"]},"author_link":[],"item_13_biblio_info_27":{"attribute_name":"bibliographic_information","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2025-06-10","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"2","bibliographicPageEnd":"32","bibliographicPageStart":"25","bibliographicVolumeNumber":"72","bibliographic_titles":[{"bibliographic_title":"Jikeikai medical journal","bibliographic_titleLang":"en"}]}]},"item_13_source_id_25":{"attribute_name":"収録物識別子","attribute_value_mlt":[{"subitem_source_identifier":"0021-6968","subitem_source_identifier_type":"PISSN"}]},"item_13_source_id_26":{"attribute_name":"書誌レコードID（総合目録DB）","attribute_value_mlt":[{"subitem_source_identifier":"AA00691585","subitem_source_identifier_type":"NCID"}]},"item_13_subject_7":{"attribute_name":"著者キーワード","attribute_value_mlt":[{"subitem_subject":"bevacizumab","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"newly diagnosed glioblastoma","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"elderly patient","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"unresectable","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"poor performance status","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_13_text_16":{"attribute_name":"著者所属","attribute_value_mlt":[{"subitem_text_language":"ja","subitem_text_value":"東京慈恵会医科大学脳神経外科学講座"}]},"item_13_text_17":{"attribute_name":"著者所属英文名","attribute_value_mlt":[{"subitem_text_language":"en","subitem_text_value":"Department of Neurosurgery, The Jikei University School of Medicine"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"東本　杏一","creatorNameLang":"ja"},{"creatorName":"トウモト　キョウイチ","creatorNameLang":"ja-Kana"},{"creatorName":"Tomoto Kyoichi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"山本　洋平","creatorNameLang":"ja"},{"creatorName":"ヤマモト　ヨウヘイ","creatorNameLang":"ja-Kana"},{"creatorName":"Yamamoto Yohei","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"勅使川原　明彦","creatorNameLang":"ja"},{"creatorName":"テシガワラ　アキヒコ","creatorNameLang":"ja-Kana"},{"creatorName":"Teshigawara Akihiko","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"村山　雄一","creatorNameLang":"ja"},{"creatorName":"ムラヤマ　ユウイチ","creatorNameLang":"ja-Kana"},{"creatorName":"Murayama Yuichi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"田中　俊英","creatorNameLang":"ja"},{"creatorName":"タナカ　トシヒデ","creatorNameLang":"ja-Kana"},{"creatorName":"Tanaka Toshihide","creatorNameLang":"en"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","filename":"72-2-25.pdf","filesize":[{"value":"661.4 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"url":"https://ir.jikei.ac.jp/record/2001779/files/72-2-25.pdf"},"version_id":"a8ab6311-2087-4aa5-b21e-ce4ff9d39c9e"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"item_resource_type","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Clinical Benefit of First-line Bevacizumab for Elderly Patients with Unresectable Glioblastoma and Poor Performance Status (Original)","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Clinical Benefit of First-line Bevacizumab for Elderly Patients with Unresectable Glioblastoma and Poor Performance Status (Original)","subitem_title_language":"en"}]},"item_type_id":"13","owner":"10","path":["1755477912960"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2025-08-18"},"publish_date":"2025-08-18","publish_status":"0","recid":"2001779","relation_version_is_last":true,"title":["Clinical Benefit of First-line Bevacizumab for Elderly Patients with Unresectable Glioblastoma and Poor Performance Status (Original)"],"weko_creator_id":"10","weko_shared_id":-1},"updated":"2025-08-18T01:29:51.678078+00:00"}